Search

Author/Creator Pollak, Richard

1. Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial. Issue 19 (27th April 2016)

Authors:
de Bruyn, Guy; Saleh, Jamshid; Workman, David; Pollak, Richard; Elinoff, Victor; Fraser, Neil J.; Lefebvre, Gigi; Martens, Mark; Mills, Richard E.; Nathan, Richard; Trevino, Miguel; van Cleeff, Martin; Foglia, Ginamarie; Ozol-Godfrey, Ayca; Patel, Dhaval M.; Pietrobon, Patricia J.; Gesser, Richard
Journal:
Vaccine
Issue:
Volume 34:Issue 19(2016)
Page Start:
2170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and efficacy of intramuscular human placenta‐derived mesenchymal stromal‐like cells (cenplacel [PDA‐002]) in patients who have a diabetic foot ulcer with peripheral arterial disease1. Issue 5 (30th January 2017)

Authors:
Wu, Stephanie C; Pollak, Richard; Frykberg, Robert G; Zhou, Wei; Karnoub, Maha; Jankovic, Vladimir; Fischkoff, Steven A; Chitkara, Denesh
Journal:
International wound journal
Issue:
Volume 14:Issue 5(2017)
Page Start:
823
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search